Should IgM/IgG rapid test kit be used in the…
For any questions or information, please email covidrapidreviewteam@gmail.com.
IgM IgG test kit V3 9Apr2020For any questions or information, please email covidrapidreviewteam@gmail.com.
IgM IgG test kit V3 9Apr2020> NOTE: The COVID-19 Living Clinical Practice Guidelines contains UPDATED recommendations and evidence summaries. Click here to be redirected to the COVID LCPG.
Through the volunteer work of more than 50 EBM practitioners, methodologists and students from the UP Institute of Clinical Epidemiology and Asia-Pacific Center for Evidence-Based HealthCare, Read more “Rapid Evidence Reviews on COVID-19 Management” →
For any questions or information, please email covidrapidreviewteam@gmail.com.
Vertical-transmission-Abridged-06Apr2020-JTFor any questions or information, please email covidrapidreviewteam@gmail.com.
Lopinavir_interferon_abridged_5Apr2020_MAIFor any questions or information, please email: covidrapidreviewteam@gmail.com.
lopinavir_ritonavir_abridged_17Apr2020_V3_MV_IGCFor any questions or information, please email: covidrapidreviewteam@gmail.com.
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Tocilizumab_Abridged_HHGB-ITGC_3Apr2020For any questions or information, please email: covidrapidreviewteam@gmail.com.
For any questions or information, please email: covidrapidreviewteam@gmail.com.
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.